Planning Directions Inc. Sells 465 Shares of The Procter & Gamble Company (NYSE:PG)

Planning Directions Inc. decreased its position in The Procter & Gamble Company (NYSE:PG) by 19.4% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 1,938 shares of the company’s stock after selling 465 shares during the period. Planning Directions Inc.’s holdings in Procter & Gamble were worth $336,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Concurrent Investment Advisors LLC raised its holdings in shares of Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after purchasing an additional 4,035 shares during the period. Radnor Capital Management LLC purchased a new position in shares of Procter & Gamble during the third quarter valued at approximately $5,705,000. Welch Group LLC grew its holdings in Procter & Gamble by 0.9% during the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after buying an additional 2,990 shares in the last quarter. GAMMA Investing LLC raised its position in Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after buying an additional 10,777 shares during the last quarter. Finally, Curi RMB Capital LLC lifted its stake in Procter & Gamble by 20.3% during the 3rd quarter. Curi RMB Capital LLC now owns 21,655 shares of the company’s stock valued at $3,751,000 after acquiring an additional 3,652 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $169.54 on Monday. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The company has a market capitalization of $399.27 billion, a PE ratio of 29.23, a P/E/G ratio of 3.67 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The company has a 50-day simple moving average of $170.32 and a two-hundred day simple moving average of $168.40.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the previous year, the business earned $1.83 EPS. The firm’s revenue for the quarter was down .6% on a year-over-year basis. Research analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.37%. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on PG shares. Evercore ISI increased their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Stifel Nicolaus lifted their target price on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research note on Monday, July 22nd. Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price objective for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. DA Davidson boosted their price objective on Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday, October 21st. Finally, TD Cowen assumed coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price for the company. Nine research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Insider Buying and Selling

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of Procter & Gamble stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. The trade was a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 313,597 shares of company stock valued at $53,268,499 over the last quarter. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.